FIDELITY SUMMER STREET TRUST's Fidelity Disruptive Medicine Fund (FMEDX) has disclosed 67 total holdings in their latest N-PORT filing with the SEC for the
portfolio date of 2023-05-31. The current portfolio value is calculated to be $43.00 Mil, only including common equities, preferred
equities, ETFs, options and warrants for equities. The turnover rate is 10%.
Fidelity Disruptive Medicine Fund (FMEDX)'s
Total Assets is $43.72 Mil , Total Liabilities is $494,760.00 , Net Assets is $43.22 Mil.
In Fidelity Disruptive Medicine Fund (FMEDX)'s current portfolio as of 2023-05-31, the top 5 holdings are
Boston Scientific Corp (BSX), UnitedHealth Group Inc (UNH), Humana Inc (HUM), Penumbra Inc (PEN) and Vertex Pharmaceuticals Inc (VRTX),
not including call and put options.
Fidelity Disruptive Medicine Fund (FMEDX) did not buy any new stocks in the current portfolio.
Please visit the "Current Portfolio" tab to see the mutual fund's current and past N-PORT holdings for Fidelity Disruptive Medicine Fund (FMEDX), as well as holding map,
valuations for each stock, which positions are undervalued, have low PE Ratios, are considered high quality and recently traded at 52-week lows, etc.
Please visit the "Stock Picks" tab to see the mutual fund's latest trades and stock picks for Fidelity Disruptive Medicine Fund (FMEDX), which include data from form N-PORT.
Please visit the "Summary" page to see the top 10 holdings, recent stock picks, performance, sector / industry breakdown details, as well as past holding history summary for Fidelity Disruptive Medicine Fund.
